Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)
A Kumari, RK Singh - Bioorganic Chemistry, 2020 - Elsevier
Morpholine is a versatile moiety, a privileged pharmacophore and an outstanding
heterocyclic motif with wide ranges of pharmacological activities due to different …
heterocyclic motif with wide ranges of pharmacological activities due to different …
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical …
AF Stepan, DP Walker, J Bauman… - Chemical research in …, 2011 - ACS Publications
Because of a preconceived notion that eliminating reactive metabolite (RM) formation with
new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM …
new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM …
Current landscape and future perspective of oxazolidinone scaffolds containing antibacterial drugs
Q Zhao, L Xin, Y Liu, C Liang, J Li, Y Jian… - Journal of Medicinal …, 2021 - ACS Publications
The widespread use of antibiotics has made the problem of bacterial resistance increasingly
serious, and the study of new drug-resistant bacteria has become the main direction of …
serious, and the study of new drug-resistant bacteria has become the main direction of …
Clinical management of Staphylococcus aureus bacteraemia
GE Thwaites, JD Edgeworth… - The Lancet infectious …, 2011 - thelancet.com
Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …
Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program
MC Birmingham, CR Rayner… - Clinical Infectious …, 2003 - academic.oup.com
Linezolid was provided for treatment of multidrug-resistant, gram-positive infections through
a compassionate-use program. Patients (n= 796) received 600 mg of linezolid intravenously …
a compassionate-use program. Patients (n= 796) received 600 mg of linezolid intravenously …
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
J Weigelt, K Itani, D Stevens, W Lau… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Skin and soft tissue infections (SSTIs) are a common cause of morbidity in both the
community and the hospital. An SSTI is classified as complicated if the infection has spread …
community and the hospital. An SSTI is classified as complicated if the infection has spread …
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme
CR Rayner, A Forrest, AK Meagher… - Clinical …, 2003 - Springer
Objective: To characterise the pharmacokinetic-pharmacodynamic relationships for linezolid
efficacy. Design and study population: Retrospective nonblinded analysis of severely …
efficacy. Design and study population: Retrospective nonblinded analysis of severely …
Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults
MP Pai - … : The Journal of Human Pharmacology and Drug …, 2012 - Wiley Online Library
The average weight of adults in the U nited S tates has increased by 25 pounds (11 kg) over
the past 50 years, with a marginal change in height. Drugs are generally dosed according to …
the past 50 years, with a marginal change in height. Drugs are generally dosed according to …
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial
DJ Stalker, GL Jungbluth - Clinical pharmacokinetics, 2003 - Springer
Linezolid is the first antibacterial to be approved from the oxazolidinone class. The drug has
substantial antimicrobial activity against Gram-positive organisms such as streptococci …
substantial antimicrobial activity against Gram-positive organisms such as streptococci …
Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections
AP MacGowan - Journal of Antimicrobial Chemotherapy, 2003 - academic.oup.com
The pharmacokinetics and pharmacodynamics of linezolid have been extensively
investigated in laboratory models, healthy volunteers and patients. Three formulations exist …
investigated in laboratory models, healthy volunteers and patients. Three formulations exist …